期刊
MAGNETIC RESONANCE IN MEDICINE
卷 75, 期 5, 页码 2107-2111出版社
WILEY
DOI: 10.1002/mrm.26151
关键词
ferumoxytol; iron oxide; safety; contrast agent
资金
- NHLBI NIH HHS [R01 HL123759] Funding Source: Medline
- NIDDK NIH HHS [R01 DK100651] Funding Source: Medline
Ferumoxytol is an ultrasmall superparamagnetic iron oxide agent marketed for the treatment of anemia. There has been increasing interest in its properties as an MRI contrast agent as well as greater awareness of its adverse event profile. This mini-review summarizes the current state of knowledge of the risks of ferumoxytol and methods of administration. Magn Reson Med 75:2107-2111, 2016. (c) 2016 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据